Skip to main content

25 April 2026

Last updated: Thursday 23 April 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Novacta targets C. difficile the natural way

Wednesday 6 May 2009

Interviewee/Contributor

Michael Dawson

Organisation

Novacta Biosystems Ltd

Novacta targets C. difficile the natural way

Wednesday 6 May 2009

Interviewee/Contributor

Tony Sedgwick

Organisation

Novacta Biosystems Ltd

Organisations

MIT Technology Licensing Office
Harvard Medical School
Bone Therapeutics SA
Howrey LLP
Alliance for Regenerative Medicine
Consultant
University of Pennsylvania, Perelman School of Medicine
Genmab A/S
Humabs BioMed SA
Eli Lilly and Company

Interviewees and Contributers

Fredrik Y Frejd
Patrik De Haes
Simon Chandler
Alexa Machikas and Elena Kfoury
Peter Verhaeghe and Eric Castaldi
Karol Sikora
Jennifer Cubino
Akshay Vaishnaw
Martin Fussenegger
Dr Matthew Wright

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Evotec appoints COO and CCO

Thursday 23 April 2026

Immunic appoints CNS expert to board

Thursday 16 April 2026

CEPI appoints board members

Thursday 16 April 2026

New CEO at Orano Med

Thursday 16 April 2026

Aravax names two board members

Thursday 16 April 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form